Terms: = Ovarian cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC AND Prognosis
2 results:
1. Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancer.
Ishibashi M; Toyoshima M; Zhang X; Hasegawa-Minato J; Shigeta S; Usui T; Kemp CJ; Grandori C; Kitatani K; Yaegashi N
Sci Rep; 2018 Sep; 8(1):13207. PubMed ID: 30181600
[TBL] [Abstract] [Full Text] [Related]
2. eIF3a improve cisplatin sensitivity in ovarian cancer by regulating xpc and p27Kip1 translation.
Zhang Y; Yu JJ; Tian Y; Li ZZ; Zhang CY; Zhang SF; Cao LQ; Zhang Y; Qian CY; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2015 Sep; 6(28):25441-51. PubMed ID: 26213845
[TBL] [Abstract] [Full Text] [Related]